Immunome Inc (IMNM)

Currency in USD
10.77
+0.17(+1.60%)
Closed·
After Hours
10.750.00(0.00%)
·
IMNM Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 14 days
Fair Value
Day's Range
10.5711.08
52 wk Range
5.1516.73
Key Statistics
Prev. Close
10.6
Open
10.77
Day's Range
10.57-11.08
52 wk Range
5.15-16.73
Volume
529.41K
Average Volume (3m)
984.99K
1-Year Change
-32.74%
Book Value / Share
3.53
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IMNM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
24.50
Upside
+127.48%
Members' Sentiments
Bearish
Bullish
ProTips
5 analysts have revised their earnings upwards for the upcoming period

Immunome Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

Immunome Inc Company Profile

Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company’s clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.

Compare IMNM to Peers and Sector

Metrics to compare
IMNM
Peers
Sector
Relationship
P/E Ratio
−4.7x−1.9x−0.5x
PEG Ratio
−0.07−0.110.00
Price/Book
3.1x2.2x2.6x
Price / LTM Sales
87.7x9.7x3.2x
Upside (Analyst Target)
118.0%153.2%42.0%
Fair Value Upside
Unlock27.9%6.6%Unlock

Analyst Ratings

9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 24.50
(+127.48% Upside)

Earnings

Latest Release
May 12, 2025
EPS / Forecast
-0.52 / -0.66
Revenue / Forecast
2.93M / 768.12K
EPS Revisions
Last 90 days

IMNM Income Statement

People Also Watch

224.68
LEU
+0.27%
50.525
SMR
+3.18%
36.27
TGTX
+2.66%
14.170
RGTI
-2.07%

FAQ

What Stock Exchange Does Immunome Trade On?

Immunome is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Immunome?

The stock symbol for Immunome is "IMNM."

What Is the Immunome Market Cap?

As of today, Immunome market cap is 937.99M.

What Is Immunome's Earnings Per Share (TTM)?

The Immunome EPS (TTM) is -3.13.

When Is the Next Immunome Earnings Date?

Immunome will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is IMNM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Immunome Stock Split?

Immunome has split 0 times.

How Many Employees Does Immunome Have?

Immunome has 131 employees.

What is the current trading status of Immunome (IMNM)?

As of 30 Jul 2025, Immunome (IMNM) is trading at a price of 10.77, with a previous close of 10.60. The stock has fluctuated within a day range of 10.57 to 11.08, while its 52-week range spans from 5.15 to 16.73.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.